Literature DB >> 6380037

Bredinin treatment in clinical kidney allografting.

A Tajima, M Hata, N Ohta, Y Ohtawara, K Suzuki, Y Aso.   

Abstract

Bredinin, a new nucleoside antibiotic isolated from Eupenicillium brefeldianum, and steroids were used as immunosuppressive agents in 31 renal transplant patients; 17 of them received grafts from living-related donors and 14 from cadavers. The one-year graft survival rates were 100% in renal recipients from living donors and 69.2% in cadaver kidney recipients. There was no serious complication from the use of these immunosuppressive agents.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6380037     DOI： 10.1097/00007890-198408000-00005

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


  4 in total

1.  Inhibition of cyclin A gene expression in human B cells by an immunosuppressant mizoribine.

Authors:  S Hirohata; K Nakanishi; T Yanagida
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

2.  A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy.

Authors:  R Shapiro; M Jordan; V Scantlebury; C Vivas; J Fung; J McCauley; A Tzakis; P Randhawa; A J Demetris; W Irish
Journal:  Clin Transplant       Date:  1994-12       Impact factor: 2.863

3.  Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine.

Authors:  L A Turka; J Dayton; G Sinclair; C B Thompson; B S Mitchell
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

Review 4.  Toward Developing Chemical Modulators of Hsp60 as Potential Therapeutics.

Authors:  Qianli Meng; Bingbing X Li; Xiangshu Xiao
Journal:  Front Mol Biosci       Date:  2018-04-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.